What is the purpose of the Merck/Schering-Plough Pharmaceuticals joint venture?
Merck & Co., Inc., and Schering-Plough Corporation formed this joint venture to develop and market new prescription medicines for cholesterol management.
Where is Merck/Schering-Plough Pharmaceuticals headquartered?
Our headquarters are located at:
351 N. Sumneytown Pike
PO Box 1000
North Wales, PA 19454
What products does Merck/Schering-Plough offer?
Currently, Merck/Schering-Plough offers 2 medicines: VYTORIN® (ezetimibe/simvastatin) and ZETIA® (ezetimibe). To learn more about these products, visit vytorin.com and zetia.com.
How do I know if the medicines developed by Merck/Schering-Plough are right for me?
Talk to your doctor to determine whether VYTORIN or ZETIA are right for you.
Who can answer my questions about Merck/Schering-Plough Pharmaceuticals?
For questions regarding press and media, contact Skip Irvine at 267-305-5397. For questions regarding VYTORIN, call 1-877-VYTORIN; for questions regarding ZETIA, call 1-800-98-ZETIA. For all other questions, call 1-866-637-2501.
Where can I find corporate information about Merck/Schering-Plough Pharmaceuticals?
Corporate information about Merck & Co., Inc., and Schering-Plough Corporation, including annual reports for these companies, is available online at merck.com and schering-plough.com.